These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29526956)
1. Rhabdomyolysis Induced by Isoniazid in a Patient with Rheumatoid Arthritis and End-stage Renal Disease: A Case Report and Review of the Literature. Komai T; Sumitomo S; Teruya S; Fujio K Intern Med; 2018 Aug; 57(16):2413-2416. PubMed ID: 29526956 [TBL] [Abstract][Full Text] [Related]
2. Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates. Simkins J; Abbo LM; Camargo JF; Rosa R; Morris MI Transplantation; 2017 Jun; 101(6):1468-1472. PubMed ID: 27548035 [TBL] [Abstract][Full Text] [Related]
3. [Development of eosinophilic pneumonia in a patient with latent tuberculosis infection resulting from isoniazid]. Umeda N; Inada Y; Mamoto T Kekkaku; 2014 Oct; 89(10):777-80. PubMed ID: 25730952 [TBL] [Abstract][Full Text] [Related]
4. Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy. Sung YK; Cho SK; Kim D; Won S; Choi CB; Kim TH; Jun JB; Yoo DH; Bae SC Korean J Intern Med; 2018 Sep; 33(5):1016-1024. PubMed ID: 28288508 [TBL] [Abstract][Full Text] [Related]
5. Minimal-change nephrotic syndrome associated with isoniazid in anti-tuberculosis chemoprophylaxis for a patient with rheumatoid arthritis. Mori S; Matsushita Y; Arizono K Intern Med; 2011; 50(3):253-7. PubMed ID: 21297330 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic. Mor A; Bingham CO; Kishimoto M; Izmirly PM; Greenberg JD; Reddy S; Rosenthal PB Ann Rheum Dis; 2008 Apr; 67(4):462-5. PubMed ID: 17711866 [TBL] [Abstract][Full Text] [Related]
7. Development of interstitial pneumonia in a patient with rheumatoid arthritis induced by isoniazid for tuberculosis chemoprophylaxis. Migita K; Umeno T; Miyagawa K; Izumi Y; Sasaki E; Kakugawa T; Ito M; Kinoshita A; Miyashita T Rheumatol Int; 2012 May; 32(5):1375-7. PubMed ID: 20349068 [TBL] [Abstract][Full Text] [Related]
8. Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection - United States, 2004-2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(8):224-9. PubMed ID: 20203555 [TBL] [Abstract][Full Text] [Related]
9. Isoniazid-induced Pure Red Cell Aplasia in a Patient with Sarcoidosis: A Patient Summary and Review of the Literature. Saito Y; Sawada Y; Koga Y; Sunaga N; Tsukagoshi Y; Hachisu Y; Osaki T; Sakurai R; Kaira K; Ono A; Sato K; Koiso H; Oyama T; Hisada T; Yamada M Intern Med; 2017 Oct; 56(20):2753-2757. PubMed ID: 28924112 [TBL] [Abstract][Full Text] [Related]
10. Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection. Gray EL; Goldberg HF Intern Med J; 2016 Mar; 46(3):281-7. PubMed ID: 26648478 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis for latent tuberculosis infection prior to anti–tumor necrosis factor therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis. Hazlewood GS; Naimark D; Gardam M; Bykerk V; Bombardier C Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1722-31. PubMed ID: 23836530 [TBL] [Abstract][Full Text] [Related]
12. Adverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis: a retrospective analysis. Fresard I; Bridevaux PO; Rochat T; Janssens JP Swiss Med Wkly; 2011; 141():w13240. PubMed ID: 21842452 [TBL] [Abstract][Full Text] [Related]
13. Mania induced by isoniazid preventive therapy during steroid treatment for rheumatoid arthritis and organising pneumonia. Nagano H; Miura T; Ueda T BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31678927 [TBL] [Abstract][Full Text] [Related]
14. The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection. Bliven EE; Podewils LJ Int J Tuberc Lung Dis; 2009 Sep; 13(9):1054-60. PubMed ID: 19723392 [TBL] [Abstract][Full Text] [Related]
16. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045 [TBL] [Abstract][Full Text] [Related]
17. Is isoniazid safe for liver transplant candidates with latent tuberculosis? Stucchi RS; Boin IF; Angerami RN; Zanaga L; Ataide EC; Udo EY Transplant Proc; 2012 Oct; 44(8):2406-10. PubMed ID: 23026607 [TBL] [Abstract][Full Text] [Related]
18. Optic neuritis with concurrent etanercept and isoniazid therapy. Noguera-Pons R; Borrás-Blasco J; Romero-Crespo I; Antón-Torres R; Navarro-Ruiz A; González-Ferrandez JA Ann Pharmacother; 2005 Dec; 39(12):2131-5. PubMed ID: 16264061 [TBL] [Abstract][Full Text] [Related]
19. [FREQUENCY AND RISK FACTORS OF SEVERE LIVER DYSFUNCTION IN ISONIAZID MONO-THERAPY FOR LATENT TUBERCULOSIS INFECTION]. Ito K Kekkaku; 2016 Sep; 91(9):607-616. PubMed ID: 30646464 [TBL] [Abstract][Full Text] [Related]
20. Treatment of latent tuberculosis infection: An update. Lobue P; Menzies D Respirology; 2010 May; 15(4):603-22. PubMed ID: 20409026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]